Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis R Lopez

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Rheumatology|June 9, 2005
Factor XIII in primary antiphospholipid syndromePaul R J Ames, Luigi Iannaccone, Jose Delgado Alves, et al.
European Journal of Rheumatology|October 7, 2016
Differential assay reactivity of immunglobulin A anti-ß<sub>2</sub> glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testingDavid B Hood, Karin R Snyder, Tammy R Buckner, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2018
Predictive Value of Oxidized Low-Density Lipoprotein/β<sub>2</sub>-Glycoprotein-I Complexes (oxLDL/β<sub>2</sub>GPI) in Nonautoimmune AtherothrombosisPaul R J Ames, Giuseppe Di Girolamo, Giovanna D'Andrea, et al.
American Journal of Clinical Pathology|September 19, 2009
Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndromeThomas P Greco, Ann Marie Conti-Kelly, Thomas Greco, et al.
Thrombosis Research|November 6, 2016
Oxidative stress reflected by increased F<sub>2</sub>-isoprostanes is associated with increasing urinary 11-dehydro thromboxane B<sub>2</sub> levels in patients with coronary artery diseasePeter A McCullough, Anupama Vasudevan, Luis R Lopez, et al.
World Journal of Diabetes|April 22, 2014
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery diseaseLuis R Lopez, Kirk E Guyer, Ignacio Garcia De La Torre, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 10, 2010
Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosisLucio Amitrano, Paul R J Ames, Maria Anna Guardascione, et al.
American Journal of Clinical Pathology|March 17, 2004
Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndromeDaniel Lopez, Ignacio Garcia-Valladares, Claudia A Palafox-Sanchez, et al.
American Clinical Laboratory|June 1, 2002
Clinical performance (sensitivity and agreement with thrombosis) of four antiphospholipid antibody assaysLuis R Lopez, Amy M Whittier, Ken J Dier, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Antiphospholipid antibodies in patients with coronary artery disease: new cardiac risk factors?Tom P Greco, Ann Marie Conti-Kelly, Eiji Matsuura, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|June 9, 2005
Factor XIII in primary antiphospholipid syndromePaul R J Ames, Luigi Iannaccone, Jose Delgado Alves, et al.
European Journal of Rheumatology|October 7, 2016
Differential assay reactivity of immunglobulin A anti-ß<sub>2</sub> glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testingDavid B Hood, Karin R Snyder, Tammy R Buckner, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2018
Predictive Value of Oxidized Low-Density Lipoprotein/β<sub>2</sub>-Glycoprotein-I Complexes (oxLDL/β<sub>2</sub>GPI) in Nonautoimmune AtherothrombosisPaul R J Ames, Giuseppe Di Girolamo, Giovanna D'Andrea, et al.
American Journal of Clinical Pathology|September 19, 2009
Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndromeThomas P Greco, Ann Marie Conti-Kelly, Thomas Greco, et al.
Thrombosis Research|November 6, 2016
Oxidative stress reflected by increased F<sub>2</sub>-isoprostanes is associated with increasing urinary 11-dehydro thromboxane B<sub>2</sub> levels in patients with coronary artery diseasePeter A McCullough, Anupama Vasudevan, Luis R Lopez, et al.
World Journal of Diabetes|April 22, 2014
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery diseaseLuis R Lopez, Kirk E Guyer, Ignacio Garcia De La Torre, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 10, 2010
Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosisLucio Amitrano, Paul R J Ames, Maria Anna Guardascione, et al.
American Journal of Clinical Pathology|March 17, 2004
Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndromeDaniel Lopez, Ignacio Garcia-Valladares, Claudia A Palafox-Sanchez, et al.
American Clinical Laboratory|June 1, 2002
Clinical performance (sensitivity and agreement with thrombosis) of four antiphospholipid antibody assaysLuis R Lopez, Amy M Whittier, Ken J Dier, et al.
Annals of the New York Academy of Sciences|September 26, 2007
Antiphospholipid antibodies in patients with coronary artery disease: new cardiac risk factors?Tom P Greco, Ann Marie Conti-Kelly, Eiji Matsuura, et al.
Pageof 4